BBA
Baker Bros. Advisors’s Kymera Therapeutics KYMR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $290M | Buy |
6,651,429
+655,500
| +11% | +$28.6M | 2.82% | 9 |
|
|
2025
Q1 | $164M | Hold |
5,995,929
| – | – | 1.82% | 9 |
|
|
2024
Q4 | $241M | Hold |
5,995,929
| – | – | 2.58% | 9 |
|
|
2024
Q3 | $284M | Buy |
5,995,929
+1
| +0% | +$47 | 2.94% | 9 |
|
|
2024
Q2 | $179M | Hold |
5,995,928
| – | – | 2.29% | 10 |
|
|
2024
Q1 | $241M | Hold |
5,995,928
| – | – | 3.02% | 7 |
|
|
2023
Q4 | $153M | Buy |
5,995,928
+1,245,528
| +26% | +$31.7M | 1.74% | 8 |
|
|
2023
Q3 | $66M | Buy |
4,750,400
+375,060
| +9% | +$5.21M | 0.38% | 19 |
|
|
2023
Q2 | $101M | Buy |
4,375,340
+1,495,515
| +52% | +$34.4M | 0.58% | 15 |
|
|
2023
Q1 | $85.3M | Hold |
2,879,825
| – | – | 0.46% | 13 |
|
|
2022
Q4 | $71.9M | Hold |
2,879,825
| – | – | 0.43% | 17 |
|
|
2022
Q3 | $62.7M | Hold |
2,879,825
| – | – | 0.41% | 23 |
|
|
2022
Q2 | $56.7M | Buy |
2,879,825
+495,083
| +21% | +$9.75M | 0.32% | 21 |
|
|
2022
Q1 | $101M | Hold |
2,384,742
| – | – | 0.58% | 14 |
|
|
2021
Q4 | $151M | Hold |
2,384,742
| – | – | 0.74% | 11 |
|
|
2021
Q3 | $140M | Buy |
2,384,742
+425,531
| +22% | +$25M | 0.62% | 15 |
|
|
2021
Q2 | $95M | Hold |
1,959,211
| – | – | 0.42% | 22 |
|
|
2021
Q1 | $76.1M | Hold |
1,959,211
| – | – | 0.33% | 28 |
|
|
2020
Q4 | $121M | Hold |
1,959,211
| – | – | 0.46% | 18 |
|
|
2020
Q3 | $63.3M | Buy |
+1,959,211
| New | +$63.3M | 0.25% | 25 |
|